The significant attraction to companies producing glucosemonitoring devices is that the business model is a classic razor-and-blade concept as an overwhelming portion of sales by these companies consists of the recurring test strips.
On Sept. 11, TheraSense of Alameda, California, which sells glucose-monitoring systems for diabetics, was doing a road show for its initial public offering.